Europe Psychedelic Drugs Market to 2032
Overview
The Europe Psychedelic Drugs Market is expected to reach a 1,064.24 USD Billion by 2032 and is projected to grow at a CAGR of 16.43% from 2025 to 2032.
Revenue, 2024 (USD Billion)
410.83
Forecast, 2032 (USD Billion)
1,064.24
CAGR, 2024 - 2032
16.43%
Report Coverage
Europe
Europe Psychedelic Drugs Market 2018-2032 USD Billion
Europe Psychedelic Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 410.83 USD Billion
- Projected Market Size (2032): 1,064.24 USD Billion
- CAGR (2025-2032): 16.43%
Key Findings of Europe Psychedelic Drugs Market
- The Europe Psychedelic Drugs Market was valued at 410.83 USD Billion in 2024.
- The Europe Psychedelic Drugs Market is likely to grow at a CAGR of 16.43% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Synthetic in Source Segment accounted for the largest share of the market with a revenue of 410.12 USD Billion
- The fastest growing segment Post-Traumatic Stress Disorder in Application Segment grew Fastest with a CAGR of 19.88% during the forecast period from 2024 to 2032.
Europe Psychedelic Drugs Market Scope
Europe Psychedelic Drugs Market Segmentation & Scope
Application
- Others
- Post-Traumatic Stress Disorder
- Opiate Addiction
- Major Depressive Disorder
- Treatment Resistant Depression
- Narcolepsy
Route of Administration
- Injectable
- Inhalation
- Oral
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hopitals Pharmacy
Drugs
- Psilocybin
- Others
- Ketamine
- Gamma-Hydroxybutyric Acid
Source
- Natural
- Synthetic
Type
- Others
- Dissociatives
- Empathogens
Europe Psychedelic Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 410.83 USD Billion |
| Market Value in 2032 | 1,064.24 USD Billion |
| CAGR (2025-2032) | 16.43% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,Route of Administration,End User,Distribution Channel,Drugs,Source,Type |
Regional Insights:
-
Leading Market (2024-2032): Europe, leading in terms of revenue 410.83 USD Billion in 2024
- Key Country: Germany, leading in terms of revenue with value of 82.91 USD Billion in 2024.
Segments and Scope
-
Europe Psychedelic Drugs Market to 2032, By Application
- Narcolepsy is the largest segment in Europe Psychedelic Drugs Market to 2032 with a revenue of 189.68 USD Billion in the year 2024.
- Post-Traumatic Stress Disorder is the Fastest growing segment in Europe Psychedelic Drugs Market to 2032 with a Growth rate of 14.65 % in forecast period 2025-2032.
-
Europe Psychedelic Drugs Market to 2032, By Route of Administration
- Oral is the largest segment in Europe Psychedelic Drugs Market to 2032 with a revenue of 313.48 USD Billion in the year 2024.
- Oral is the Fastest growing segment in Europe Psychedelic Drugs Market to 2032 with a Growth rate of 17.47 % in forecast period 2025-2032.
-
Europe Psychedelic Drugs Market to 2032, By End User
- Hospitals is the largest segment in Europe Psychedelic Drugs Market to 2032 with a revenue of 227.38 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Europe Psychedelic Drugs Market to 2032 with a Growth rate of 17.22 % in forecast period 2025-2032.
-
Europe Psychedelic Drugs Market to 2032, By Distribution Channel
- Hopitals Pharmacy is the largest segment in Europe Psychedelic Drugs Market to 2032 with a revenue of 274.79 USD Billion in the year 2024.
- Hopitals Pharmacy is the Fastest growing segment in Europe Psychedelic Drugs Market to 2032 with a Growth rate of 17.21 % in forecast period 2025-2032.
-
Europe Psychedelic Drugs Market to 2032, By Drugs
- Gamma-Hydroxybutyric Acid is the largest segment in Europe Psychedelic Drugs Market to 2032 with a revenue of 304.54 USD Billion in the year 2024.
- Gamma-Hydroxybutyric Acid is the Fastest growing segment in Europe Psychedelic Drugs Market to 2032 with a Growth rate of 16.65 % in forecast period 2025-2032.
-
Europe Psychedelic Drugs Market to 2032, By Source
- Synthetic is the largest segment in Europe Psychedelic Drugs Market to 2032 with a revenue of 410.12 USD Billion in the year 2024.
- Synthetic is the Fastest growing segment in Europe Psychedelic Drugs Market to 2032 with a Growth rate of 16.43 % in forecast period 2025-2032.
-
Europe Psychedelic Drugs Market to 2032, By Type
- Empathogens is the largest segment in Europe Psychedelic Drugs Market to 2032 with a revenue of 301.27 USD Billion in the year 2024.
- Empathogens is the Fastest growing segment in Europe Psychedelic Drugs Market to 2032 with a Growth rate of 16.96 % in forecast period 2025-2032.
Europe Psychedelic Drugs Market Company Share Analysis
| Company Name |
|
||
| Medtronic | |||
| Jazz Pharmaceuticals, Inc. | |||
| Janssen Global Services, LLC | |||
| ICU Medical, Inc. | |||
| Stryker | |||
Europe Psychedelic Drugs Market Geographical Sales Distribution, 2018-2032 USD Billion
Europe Psychedelic Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Europe Psychedelic Drugs Market is segmented based on Segmentation Application,Route of Administration,End User,Distribution Channel,Drugs,Source,Type.
Europe Psychedelic Drugs Market was valued at USD 410.83(Revenue in USD Billion) in 2022.
Europe Psychedelic Drugs Market is projected to grow at a CAGR of 16.43% during the forecast period of 2024 to 2032.
The Synthetic segment is expected to dominate the Europe Psychedelic Drugs Market, holding a largest market share of 410.12 USD Billion in 2024
Europe Psychedelic Drugs Market Scope
Europe Psychedelic Drugs Market Segmentation & Scope
Application
- Others
- Post-Traumatic Stress Disorder
- Opiate Addiction
- Major Depressive Disorder
- Treatment Resistant Depression
- Narcolepsy
Route of Administration
- Injectable
- Inhalation
- Oral
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hopitals Pharmacy
Drugs
- Psilocybin
- Others
- Ketamine
- Gamma-Hydroxybutyric Acid
Source
- Natural
- Synthetic
Type
- Others
- Dissociatives
- Empathogens
Frequently Asked Questions
The Europe Psychedelic Drugs Market is segmented based on Segmentation Application,Route of Administration,End User,Distribution Channel,Drugs,Source,Type.
Europe Psychedelic Drugs Market was valued at USD 410.83(Revenue in USD Billion) in 2022.
Europe Psychedelic Drugs Market is projected to grow at a CAGR of 16.43% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Psychedelic Drugs Market for final year is USD 1,064.24 (USD Billion).
Europe Psychedelic Drugs Market Company Profiling
Frequently Asked Questions
The Europe Psychedelic Drugs Market is segmented based on Segmentation Application,Route of Administration,End User,Distribution Channel,Drugs,Source,Type.
Europe Psychedelic Drugs Market was valued at USD 410.83(Revenue in USD Billion) in 2022.
Europe Psychedelic Drugs Market is projected to grow at a CAGR of 16.43% during the forecast period of 2024 to 2032.
The estimated market value of the Europe Psychedelic Drugs Market for final year is USD 1,064.24 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.